相似文献
1
Novel Molecular Methods in Soft Tissue Sarcomas: From Diagnostics to Theragnostics.
Cancers (Basel). 2025 Apr 3;17(7):1215. doi: 10.3390/cancers17071215.
2
Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors.
J Surg Oncol. 2015 Apr;111(5):520-31. doi: 10.1002/jso.23882. Epub 2015 Mar 13.
3
Hypermethylation of potential tumor suppressor miR-34b/c is correlated with late clinical stage in patients with soft tissue sarcomas.
Exp Mol Pathol. 2015 Jun;98(3):446-54. doi: 10.1016/j.yexmp.2015.03.017. Epub 2015 Mar 13.
4
[Preoperative diagnostics and typing of abdominal soft tissue sarcomas].
Chirurg. 2022 Jan;93(1):5-15. doi: 10.1007/s00104-021-01528-0. Epub 2021 Nov 10.
5
Several types of soft tissue sarcomas originate from the malignant transformation of adipose tissue-derived stem cells.
Mol Med Rep. 2010 May-Jun;3(3):441-8. doi: 10.3892/mmr_00000277.
6
Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma.
Curr Oncol. 2022 Sep 7;29(9):6400-6418. doi: 10.3390/curroncol29090504.
7
Preclinical Models of Visceral Sarcomas.
Biomolecules. 2023 Nov 6;13(11):1624. doi: 10.3390/biom13111624.
8
Epigenetic and genetic changes in soft tissue sarcomas: a review.
APMIS. 2016 Nov;124(11):925-934. doi: 10.1111/apm.12600. Epub 2016 Sep 27.
9
Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives.
Radiol Med. 2019 Apr;124(4):259-265. doi: 10.1007/s11547-018-0883-6. Epub 2018 Apr 4.
10
Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
Cancer. 1994 Aug 1;74(3):842-7. doi: 10.1002/1097-0142(19940801)74:3<842::aid-cncr2820740309>3.0.co;2-b.
引用本文的文献
1
Integrating Radiogenomics and Machine Learning in Musculoskeletal Oncology Care.
Diagnostics (Basel). 2025 May 29;15(11):1377. doi: 10.3390/diagnostics15111377.
本文引用的文献
1
Soft tissue sarcomas at the single-cell and spatial resolution: new markers and targets.
Cancer Gene Ther. 2025 Jan;32(1):11-21. doi: 10.1038/s41417-024-00856-7. Epub 2024 Nov 24.
2
Investigating the Use of Circulating Tumor DNA for Sarcoma Management.
J Clin Med. 2024 Oct 31;13(21):6539. doi: 10.3390/jcm13216539.
3
Introduction and impact of routine whole genome sequencing in the diagnosis and management of sarcoma.
Br J Cancer. 2024 Sep;131(5):860-869. doi: 10.1038/s41416-024-02721-8. Epub 2024 Jul 12.
4
Advances in spatial transcriptomics and its applications in cancer research.
Mol Cancer. 2024 Jun 20;23(1):129. doi: 10.1186/s12943-024-02040-9.
5
Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society for Immunotherapy of Cancer.
J Mol Diagn. 2024 Aug;26(8):653-668. doi: 10.1016/j.jmoldx.2024.05.002. Epub 2024 Jun 6.
6
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma.
Clin Cancer Res. 2024 Jun 14;30(12):2647-2658. doi: 10.1158/1078-0432.CCR-24-0384.
7
Deciphering the tumor immune microenvironment of imatinib-resistance in advanced gastrointestinal stromal tumors at single-cell resolution.
Cell Death Dis. 2024 Mar 5;15(3):190. doi: 10.1038/s41419-024-06571-3.
8
Machine Learning-Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA Sequencing.
J Mol Diagn. 2024 May;26(5):387-398. doi: 10.1016/j.jmoldx.2024.02.002. Epub 2024 Feb 21.
9
Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Clin Orthop Relat Res. 2024 Mar 1;482(3):549-563. doi: 10.1097/CORR.0000000000002901. Epub 2023 Nov 28.
10
Extensive analysis of 59 sarcoma-related fusion genes identified pazopanib as a potential inhibitor to COL1A1-PDGFB fusion gene.
Cancer Sci. 2023 Oct;114(10):4089-4100. doi: 10.1111/cas.15915. Epub 2023 Aug 17.
Zotero 插件